--- Chain 8 for Question 88 ---
Status: USED_FOR_VOTING
Finish Reason (Model): stop
Extracted Answer: A
Prompt Tokens (Usage): 168
Completion Tokens (Usage): 781
Reasoning Tokens (Counted): 531
Non-Reasoning Tokens (Counted): 248
Total Tokens (Usage): 949

--- Reasoning Content ---
Okay, so I've got this question about rotavirus and some experiments done with GFP-tagged proteins. Hmm, let's try to break this down step by step.

So the setup is that they tagged the inner capsid proteins of rotavirus with GFP and gave them to mice orally. Then they did in vivo imaging and saw some fluorescence destroyed by stomach acid, some entangled in mucus before reaching secondary lymphoid organs. They found the fluorescent Peyer's patches and isolated the proliferating cells. Sequencing the variable heavy chain genes showed high variability. The question is asking which process is happening.

Wait, I remember that Peyer's patches are part of the gut-associated lymphoid tissue (GALT), right? They're specialized for sampling antigens in the intestine. So when the rotavirus proteins are delivered via oral gavage, they should be taken up by these patches.

The fluorescent proteins were destroyed by stomach acid or mucus, which makes sense because the stomach has a lot of acid, and the small intestine has mucus. So some of the GFP might get degraded before they reach the lymphoid tissues. But some did make it to the Peyer's patches.

In the Peyer's patches, the antigen-presenting cells, like dendritic cells or M cells, probably take up the rotavirus proteins. Then these antigens are processed and presented to B cells. That's when the immune response starts.

The next part is that they isolated the proliferating cell population. Proliferating cells in lymphoid tissues are likely activated B cells. When B cells are activated, they start to proliferate and differentiate. But why is the variable heavy chain gene showing high variability?

Oh, right! High variability in the variable regions suggests that a process called somatic hypermutation is happening. Somatic hypermutation is a process where B cells introduce mutations into the variable regions of their immunoglobulin genes during the immune response. This increases the diversity of antibodies and allows for a better match to the antigen.

Let me think about the other options. Complement activation is part of the immune response, but it doesn't directly cause variability in the heavy chain. Class switching recombination changes the class of antibody (like from IgM to IgG), but that doesn't affect the variability in the variable regions. VDJ recombination happens during the initial formation of B cells in the bone marrow, setting up the initial diversity. But here, the process is happening after the B cells have already been activated, so it's more likely to be somatic hypermutation.

So the process is somatic hypermutation. That's option A.


--- Final Answer Content ---


The experiment involves tagging rotavirus inner capsid proteins with GFP and delivering them to mice via oral gavage. Some fluorescence is lost due to stomach acid and mucus, but the remaining GFP-tagged proteins reach the Peyer's patches, which are specialized lymphoid tissues in the gut. These patches sample antigens and initiate immune responses. The fluorescent Peyer's patches are isolated, and the proliferating cell population is analyzed. Sequencing the variable heavy chain genes of these cells reveals high variability.

High variability in the variable heavy chain genes suggests that somatic hypermutation is occurring. This process introduces mutations into the variable regions of B cell immunoglobulin genes after antigen activation, increasing antibody diversity. Other options, such as complement activation, class switching recombination, and VDJ recombination, do not directly explain the observed variability in the variable heavy chain genes. Complement activation facilitates immune responses but does not mutate genes. Class switching recombination alters the antibody isotype but does not affect variability in the variable region. VDJ recombination occurs during B cell development in the bone marrow, not during the immune response in secondary lymphoid tissues.

Thus, the process responsible for the observed variability is somatic hypermutation.

Answer: A

--- Full Content ---
Okay, so I've got this question about rotavirus and some experiments done with GFP-tagged proteins. Hmm, let's try to break this down step by step.

So the setup is that they tagged the inner capsid proteins of rotavirus with GFP and gave them to mice orally. Then they did in vivo imaging and saw some fluorescence destroyed by stomach acid, some entangled in mucus before reaching secondary lymphoid organs. They found the fluorescent Peyer's patches and isolated the proliferating cells. Sequencing the variable heavy chain genes showed high variability. The question is asking which process is happening.

Wait, I remember that Peyer's patches are part of the gut-associated lymphoid tissue (GALT), right? They're specialized for sampling antigens in the intestine. So when the rotavirus proteins are delivered via oral gavage, they should be taken up by these patches.

The fluorescent proteins were destroyed by stomach acid or mucus, which makes sense because the stomach has a lot of acid, and the small intestine has mucus. So some of the GFP might get degraded before they reach the lymphoid tissues. But some did make it to the Peyer's patches.

In the Peyer's patches, the antigen-presenting cells, like dendritic cells or M cells, probably take up the rotavirus proteins. Then these antigens are processed and presented to B cells. That's when the immune response starts.

The next part is that they isolated the proliferating cell population. Proliferating cells in lymphoid tissues are likely activated B cells. When B cells are activated, they start to proliferate and differentiate. But why is the variable heavy chain gene showing high variability?

Oh, right! High variability in the variable regions suggests that a process called somatic hypermutation is happening. Somatic hypermutation is a process where B cells introduce mutations into the variable regions of their immunoglobulin genes during the immune response. This increases the diversity of antibodies and allows for a better match to the antigen.

Let me think about the other options. Complement activation is part of the immune response, but it doesn't directly cause variability in the heavy chain. Class switching recombination changes the class of antibody (like from IgM to IgG), but that doesn't affect the variability in the variable regions. VDJ recombination happens during the initial formation of B cells in the bone marrow, setting up the initial diversity. But here, the process is happening after the B cells have already been activated, so it's more likely to be somatic hypermutation.

So the process is somatic hypermutation. That's option A.


The experiment involves tagging rotavirus inner capsid proteins with GFP and delivering them to mice via oral gavage. Some fluorescence is lost due to stomach acid and mucus, but the remaining GFP-tagged proteins reach the Peyer's patches, which are specialized lymphoid tissues in the gut. These patches sample antigens and initiate immune responses. The fluorescent Peyer's patches are isolated, and the proliferating cell population is analyzed. Sequencing the variable heavy chain genes of these cells reveals high variability.

High variability in the variable heavy chain genes suggests that somatic hypermutation is occurring. This process introduces mutations into the variable regions of B cell immunoglobulin genes after antigen activation, increasing antibody diversity. Other options, such as complement activation, class switching recombination, and VDJ recombination, do not directly explain the observed variability in the variable heavy chain genes. Complement activation facilitates immune responses but does not mutate genes. Class switching recombination alters the antibody isotype but does not affect variability in the variable region. VDJ recombination occurs during B cell development in the bone marrow, not during the immune response in secondary lymphoid tissues.

Thus, the process responsible for the observed variability is somatic hypermutation.

Answer: A